Progyny Inc (NASDAQ: PGNY) started the day on Thursday, with a price increase of 1.24% at $14.71, before settling in for the price of $14.53 at the close. Taking a more long-term approach, PGNY posted a 52-week range of $13.39-$42.08.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 61.75% for the last half of the decade. Nevertheless, stock’s Earnings Per Share (EPS) this year is -13.23%. This publicly-traded company’s shares outstanding now amounts to $88.34 million, simultaneously with a float of $71.52 million. The organization now has a market capitalization sitting at $1.25 billion. At the time of writing, stock’s 50-day Moving Average stood at $15.29, while the 200-day Moving Average is $24.08.
Progyny Inc (PGNY) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Health Information Services Industry. Progyny Inc’s current insider ownership accounts for 16.01%, in contrast to 91.55% institutional ownership. According to the most recent insider trade that took place on Dec 26 ’24, this organization’s Executive Chairman bought 150,000 shares at the rate of 14.68, making the entire transaction reach 2,202,330 in total value, affecting insider ownership by 228,269. Preceding that transaction, on Dec 23 ’24, Company’s CHIEF EXECUTIVE OFFICER bought 209,500 for 14.48, making the whole transaction’s value amount to 3,034,084. This particular insider is now the holder of 441,463 in total.
Progyny Inc (PGNY) Earnings and Revenue Records
Progyny Inc’s EPS decrease for this current 12-month fiscal period is -13.23% and is forecasted to reach 0.59 in the upcoming year.
Progyny Inc (NASDAQ: PGNY) Trading Performance Indicators
Let’s observe the current performance indicators for Progyny Inc (PGNY). It’s Quick Ratio in the last reported quarter now stands at 2.62. The Stock has managed to achieve an average true range (ATR) of 0.60. Alongside those numbers, its PE Ratio stands at $25.34, and its Beta score is 1.35. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.10. Similarly, its price to free cash flow for trailing twelve months is now 7.81.
In the same vein, PGNY’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.58, a figure that is expected to reach 0.09 in the next quarter, and analysts are predicting that it will be 0.59 at the market close of one year from today.
Technical Analysis of Progyny Inc (PGNY)
If we take a close look at the recent performances of Progyny Inc (NASDAQ: PGNY), its last 5-days Average volume was 2.39 million that shows progress from its year to date volume of 1.42 million. During the previous 9 days, stock’s Stochastic %D was recorded 48.13% While, its Average True Range was 0.56.
Raw Stochastic average of Progyny Inc (PGNY) in the period of the previous 100 days is set at 10.43%, which indicates a major fall in contrast to 39.35% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 40.00% that was lower than 86.20% volatility it exhibited in the past 100-days period.
